Chávez-Saldaña M, García-Cavazos R, Vigueras RM, Orozco L

Language: English
References: 9
Page: 433-435
PDF size: 61.18 Kb.

ABSTRACT

Introduction. The high genetic heterogeneity in populations with a wide spectrum of mutations in the CF transmembrane conductance regulator gene (CFTR), makes the detection of mutations a very hard and difficult task, thereby limiting the accurate diagnosis of the disease, mainly in patients with uncharacterized mutations. Material and methods. Molecular strategies, like targeted identification of the most frequent CFTR mutations in Mexican population combined with linkage analysis using markers, is very useful for carrier detection and for prenatal diagnosis in affected families with CF. In this paper we show that the combination of methodologies was a crucial alternative to reach a precise prenatal CF diagnosis. We documented CF diagnosis in a 14th-week fetus combining the screening of the most common mutations in Mexican population with linkage analysis of two extragenic polymorphisms (XV2C/TaqI and KM19/PstI). Results. We determined that the fetus inherited the P.G542X mutation from its mother and an unknown mutation from its father through the chromosomal phases analysis.

REFERENCES

1. Chávez-Saldaña M, Lezana JL, Carnevale A, Macías M, Vigueras- Rosa M, Orozco L. CFTR gene’s mutational spectrum in Mexican patients diagnosed with cystic fibrosis. Memories of the 59th Annual Meeting, American Society of Human Genetics, Honolulu, Hawaii 21-24 October, 218, 2009.

2. Estivill X, Scambler PJ, Wainwright BJ, Hawley K, Frederick PA, Schwartz M, et al. Patterns of polymorphism all linkage disequilibrium for Cystic fibrosis. Genomics 1987; 1: 257-63.

3. Orozco L, Velázquez R, Zielenski J, Lap-Chee T, Chávez M, Lezana JL, et al. Spectrum of CFTR mutations in Mexican cystic fibrosis patients: identification of five novel mutations (W1098C, 846delT, P750L, 4160insGGGG and 297-1G→A). Human Gen 2000; 106: 360-5.

4. Sambrook J, Fritisch EF, Maniatis T. Molecular Cloning. A Laboratory Manual. In: Isolation of DNA from Mammalian Cells: Protocol 1. Book 2. 2nd. Ed. New York: Cold Spring Habor Laboratory Press; 1989.

5. Ley General de Salud. Nueva ley publicada en el Diario Oficial de la Federación el 7 de febrero de 1984. Texto vigente. Última reforma publicada DOF 19-09-2006.

6. Declaración universal sobre el genoma humano y los derechos humanos. Conferencia General de las Naciones Unidas para La Educación, la Ciencia y la Cultura en su 29a. Reunión.

7. Rosenbloom CL, Kerem BS, Romens JM, Tsui L-C, Wanwright B, Williamson R, et al. DNA amplification for detection of the XV-2c polymorphism linked to cystic fibrosis. Nucleic Acids Res 1989; 17: 7117.

8. Anwar R, Murray K, Hedge PJ, Smith JC, Markham AF. DNA sequence analysis of the KM19 locus linked to cystic fibrosis. Design of new oligonucleotides to remove non-specific PCR products. Hum Genet 1990; 85: 319-23.

9. Orozco L, González L, Chávez M, Velásquez R, Lezana JL, Saldaña Y, et al. XV-2c/KM-19 haplotype analysis of cystic fibrosis mutations in Mexican patients. Am J Med Genet 2001; 102: 277-81.